Managed Care

In today's complex health environment, payers are challenged to efficiently allocate resources while striving to improve quality of care.

In the world of high-risk obstetrics, this challenge is becoming increasingly more difficult. Preterm birth is on the rise, and 57% of the annual $10.2 billion spent on newborn care is being disproportionately consumed by the 10% of infants who are born preterm.* Such statistics make identifying the products and services that are fiscally responsible and improve the quality of patient care a necessity.

AmniSure International LLC meets this need for health plans by collecting market information, data, and society statements on the economic and clinical effectiveness of the AmniSure ROM Test. Additional information can be provided via our dossier, which can be accessed by contacting us.

  • pregnant woman

    Unmet Need

    The AmniSure ROM Test addresses the longstanding need for a rapid, reliable, and noninvasive aid to diagnose the rupture of fetal membranes.

    Learn More »
  • holding a baby's hand

    Clinical Utility

    The AmniSure ROM Test is clinically useful in three distinct ways. Improved Patient Outcomes, Improved Physician Confidence and Use of AmniSure as Reference Method.

    Learn More »
  • girl listening to baby's heartbeat

    Cost-Effectiveness

    The AmniSure ROM Test provides a cost-effective diagnostic that aids clinicians in providing quality patient care.

    Learn More »
  • nurse with clipboard

    What is the AmniSure ROM Test?

    What is the AmniSure ROM Test? The AmniSure ROM Test is an FDA-cleared diagnostic device (Rx only) that solves a long-standing problem in obstetric practice - diagnosis of Premature Rupture of Membranes (PROM).

    Learn More »

Questions?

Contact An AmniSure Sales Rep for Assistance